A/Prof David Schultz obtained his BMBS at Flinders University of South Australia, and trained as a neurologist in Australia and the UK. He is now Head of Neurology and Stroke for the Southern Adelaide Local Health Network in South Australia, as well as the lead neurologist for the statewide MND clinic based at Flinders Medical Centre. He is a member of the Fight MND Clinical Trials & Translational Research Advisory Committee. He has established a successful track record in clinical trials, successfully recruiting many patients into a variety of trials, for various neurological disorders including acute treatments and secondary prevention of stroke, migraine and multiple sclerosis. In the last 10 years, his research emphasis has been in MND, being the site principal investigator in a number of national and international MND trials, and partnering with A/Prof Mary-Louise Rogers at Flinders University to assist in the discovery of urinary p75ECD as a biomarker for MND.
